Authors/Disclosures
|
Kunio Nakamura, PhD
(Cleveland Clinic)
|
Dr. Nakamura has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for INmune Bio. The institution of Dr. Nakamura has received research support from Biogen. The institution of Dr. Nakamura has received research support from PCORI. The institution of Dr. Nakamura has received research support from NIH. The institution of Dr. Nakamura has received research support from Genzyme. The institution of Dr. Nakamura has received research support from NIH. The institution of Dr. Nakamura has received research support from Genzyme. The institution of Dr. Nakamura has received research support from Novartis. The institution of Dr. Nakamura has received research support from DOD. Dr. Nakamura has received intellectual property interests from a discovery or technology relating to health care. |
|
Richard A. Rudick, MD, FAAN
(Optimal Brain Health Consultants)
|
Dr. Rudick has received personal compensation for serving as an employee of Biogen. Dr. Rudick has received stock or an ownership interest from Biogen. Dr. Rudick has received publishing royalties from a publication relating to health care. |
|
|
No disclosure on file |
|
|
No disclosure on file |
|
Pamela Foulds, MD
(Biogen Idec)
|
No disclosure on file |
|
Elizabeth Fisher, PhD
(Dept of Biomedical Engineering/WB3)
|
No disclosure on file |
|
Michael Y. Xu, MD, FAAN
(California University of Science and Medicine)
|
No disclosure on file |